15 | gadolinium ethoxybenzyl DTPAFDA Link
06/2016
-
01/2010 |
11 | Contrast MediaIBA
01/2016
-
01/2002 |
8 | GadoliniumIBA
01/2016
-
05/2007 |
5 | Therapeutic UsesIBA
09/2016
-
05/2002 |
5 | ferric oxide (iron oxide)IBA
12/2009
-
02/2006 |
4 | N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamideIBA
01/2016
-
10/2013 |
4 | allogenic effect factor (AEF)IBA
01/2013
-
02/2009 |
3 | SolutionsIBA
11/2013
-
01/2004 |
3 | Gadolinium DTPA (Magnevist)FDA Link
01/2013
-
09/2003 |
3 | gadobenic acid (gadobenate dimeglumine)FDA Link
08/2008
-
03/2008 |
2 | Capsules (Microcapsules)IBA
12/2017
-
07/2012 |
2 | thiamine triphosphorate (TTP)IBA
10/2017
-
03/2011 |
2 | GemcitabineFDA Link
09/2016
-
11/2013 |
2 | gadobutrolIBA
10/2015
-
04/2010 |
2 | CholesterolIBA
11/2014
-
12/2010 |
2 | alpha-Fetoproteins (alpha-Fetoprotein)IBA
06/2014
-
10/2004 |
2 | gadofluorine MIBA
05/2012
-
05/2012 |
2 | SHU 508 (Levovist)IBA
04/2005
-
01/2002 |
2 | BilirubinIBA
10/2004
-
08/2002 |
1 | nasIBA
12/2021 |
1 | EnzymesIBA
01/2021 |
1 | IronIBA
03/2020 |
1 | LuciferasesIBA
09/2016 |
1 | gadoterate meglumineIBA
09/2015 |
1 | contrast agent P792IBA
09/2015 |
1 | gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
09/2015 |
1 | LipidsIBA
03/2015 |
1 | contrast agent BR1IBA
01/2014 |
1 | Fibronectins (Fibronectin)IBA
01/2014 |
1 | Hematoxylin (Haematoxylon)IBA
11/2013 |
1 | DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
11/2013 |
1 | Eosine Yellowish-(YS) (Eosin)IBA
11/2013 |
1 | Coloring Agents (Dyes)IBA
11/2013 |
1 | TubulinIBA
10/2013 |
1 | Biomarkers (Surrogate Marker)IBA
06/2013 |
1 | antineoplaston A10 (A 10)IBA
03/2013 |
1 | Polytetrafluoroethylene (Teflon)FDA Link
11/2012 |
1 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2012 |
1 | IodineIBA
02/2011 |
1 | Sorafenib (BAY 43-9006)FDA Link
09/2010 |
1 | Glucose (Dextrose)FDA LinkGeneric
08/2010 |